Arora, Sumit
Pansari, Amita
Kilford, Peter J. http://orcid.org/0000-0002-3333-7350
Jamei, Masoud
Turner, David B.
Gardner, Iain
Article History
Accepted: 10 March 2022
First Online: 29 April 2022
Declarations
:
: The activities of Certara UK, Simcyp Division are supported by the Simcyp Consortium of pharmaceutical companies. No other source of funding was used for the work.
: At the time of the work, Sumit Arora was employed by Certara UK Limited and may hold shares in the company. At the time of the work, Peter Kilford was employed by Certara UK Limited and may hold shares in the company. Amita Pansari is employed by Certara UK Limited and may hold shares in the company. David Turner is employed by Certara UK Limited and may hold shares in the company. Iain Gardner is employed by Certara UK Limited and may hold shares in the company. Masoud Jamei is employed by Certara UK Limited and may hold shares in the company.
: SA, PK, AP, DT, IG, and MJ wrote the manuscript; SA, AP, and PK designed the research; SA, AP, PK, and IG performed the research; SA, AP, PK, and IG analysed the data.
: This was a simulation study and did not involve any clinical studies, and therefore ethics approval was not needed.
: Not applicable.
: Not applicable.
: The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
: The workspaces used to run the simulation are available from the corresponding author on reasonable request.